scispace - formally typeset
D

David P. Nicolau

Researcher at Hartford Hospital

Publications -  791
Citations -  20967

David P. Nicolau is an academic researcher from Hartford Hospital. The author has contributed to research in topics: Meropenem & Tazobactam. The author has an hindex of 60, co-authored 749 publications receiving 18295 citations. Previous affiliations of David P. Nicolau include University of Connecticut.

Papers
More filters
Journal ArticleDOI

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.

TL;DR: An ODA program at this institution that utilizes a fixed 7-mg/kg intravenous dose with a drug administration interval based on estimated creatinine clearance appears to be clinically effective, reduces the incidence of nephrotoxicity, and provides a cost-effective method for administration of aminoglycosides by reducing ancillary service time and serum am inoglycoside determinations.
Journal ArticleDOI

Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections

TL;DR: Due to 100% fT > MIC achieved in the majority of LRTI patients, fCmin/MIC was the statistically significant parameter associated with meropenem clinical and microbiological response in the adults with LRTi.
Journal ArticleDOI

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.

TL;DR: There are some patient populations that have not been adequately studied to determine whether or not once-daily aminoglycoside dosing would be a better choice than traditional dosing regimens, and a similar regimen can be applied to amikacin dosing.
Journal ArticleDOI

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

TL;DR: Levofloxacin, owing to its larger AUC0–24 values, has excellent and sustained activity against different pneumococcal strains superior to that of ciprofloxacins, and ampicillin showed rapid and sustained bactericidal activity against all isolates.
Journal ArticleDOI

The pharmacodynamics of aminoglycosides

TL;DR: A more complete understanding of the pharmacodynamics of aminoglycosides has been recognized, indicating that this class of antibiotics exhibits both concentration-dependent bactericidal activity and a postantibiotic effect.